Gossamer Bio, Inc. (GOSS)
NGS · Common · CUSIP 38341P102
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for GOSS and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
38341P102
Market Cap
Mid Cap
IPO
2/8/2019 · $16.00/share
Business: Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.

Company Contact

CEO
Faheem Hasnain
CFO
Bryan Giraudo
Headquarters
3115 Merryfield Row, Suite 120, San Diego, CA 92121
Phone
858-684-1300
Investor Relations
Bryan Giraudo · 858-684-1300 · ir@gossamerbio.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »